Scrip's Five Must-Know Things - 22 April 2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs. https://scrip.citeline.com/SC150134/Quick-Listen-Scrips-Five-MustKnow-Things Other podcasts in this series: https://on.soundcloud.com/xSKGyTJnAYS66apP9